Details for 2017175788

Up to date per 01.04.2026

Actions

Title / Product Name

APIXABAN-FORMULIERUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2017175788

EP Publication Number

3251660

E-Number

1190613

Language

PCT Number

Publication Date

06.12.2017 A

16.10.2019 B1

Registration Date

16.10.2019

AT Publication Date

15.11.2019

Application Date

24.02.2011

Registration Number

Priorities

25.02.2010

308056 P

IPC

A61K 9/20 20060101AFI20190624BHEP

Maximum Duration of Protection

24.02.2031

Owner

Bristol-Myers Squibb Holdings Ireland Unlimited CompanyHinterbergstrasse 16 6312 SteinhausenCH

Pfizer Inc.235 East 42nd Street New York, NY 10017US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

PATEL, Jatinc/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princton, NJ New Jersey 08543US

FROST, Charlesc/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princton, NJ New Jersey 08543US

JIA, Jingpinc/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princton, NJ New Jersey 08543US

VEMA-VARAPU, Chandrac/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princton, NJ New Jersey 08543US